Related Experiment Video
Updated: Jun 25, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Cancer-associated venous thrombosis in the surgical setting
Kasim A Behranwala1, Robin C N Williamson
1Department of Surgery, Hammersmith Hospital, London, UK. kbehranwala@hotmail.com
Objective:
Cancer patients are at a relatively high risk of venous thromboembolism (VTE), and this has implications for surgical outcome.
Data Source:
English literature search including the keywords cancer, surgery and VTE was undertaken to review the risk, etiology, prevention and treatment of VTE in surgical oncology patients.
Data Synthesis:
Malignant disease is highlighted as an important risk factor for VTE with an odds ratio of 6.5. The risk factors include higher age, previous VTE, advanced cancer, length of operation and immobility.
Conclusions:
Use of in-hospital thromboprophylaxis with low-molecular-weight heparin (LMWH) or low dose unfractionated heparin with graded stockings has been validated both in terms of safety and efficacy and should be considered for all patients. Subcutaneous LMWH has replaced unfractionated heparin for the initial treatment of VTE. The use of long-term LMWH instead of oral anticoagulants can substantially reduce the risk of recurrent VTE without increased bleeding. Recently, results of few trials have shown that LMWH may improve patient survival.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
